BARD1 regulates BRCA1-mediated transactivation of the p21WAF1/CIP1 and Gadd45 promoters

Cancer Letters

Volumn 263, Issue 2, 2008, Pages 189-196

  Fabbro, Megan ^a   Henderson, Beric R ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

BARD1; BRCA1; Breast cancer; Nuclear transport; Transcription

Indexed keywords

BRCA1 ASSOCIATED RING DOMAIN PROTEIN 1; BRCA1 PROTEIN; CYCLIN DEPENDENT KINASE INHIBITOR 1; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 45; UBIQUITIN PROTEIN LIGASE E3;

ARTICLE; BREAST CANCER; CANCER INHIBITION; CONTROLLED STUDY; ENZYME ACTIVITY; GENE CONTROL; GENE MUTATION; HUMAN; HUMAN CELL; ONCOGENE; PRIORITY JOURNAL; TRANSACTIVATION; TRANSCRIPTION REGULATION;

BRCA1 PROTEIN; BREAST NEOPLASMS; CELL CYCLE PROTEINS; CELL LINE, TUMOR; CELL NUCLEUS; CYCLIN-DEPENDENT KINASE INHIBITOR P21; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MUTATION; NUCLEAR PROTEINS; PROMOTER REGIONS (GENETICS); TRANS-ACTIVATION (GENETICS); TRANSFECTION; TUMOR SUPPRESSOR PROTEINS; UBIQUITIN-PROTEIN LIGASES;

EID: 41649115598     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2008.01.001     Document Type: Article

References (30)

1. Miki Y., Swensen J., Shattuck-Eidens D., Futreal P.A., Ahrshman K., Tavigian S., Liu Q., Cochran C., Bennett L.M., Ding W., Bell R., Rosenthal J., Hussey C., Tran T., McClure M., Frye C., Hattier T., Phelps R., Haugen-Strano A., Katcher H., Yakumo K., Gholmai A., Shaffer D., Stone S., Bayer S., Wray C., Bogden R., Dayananth P., Ward J., Tonin P., Narod S., Bristow P.K., Norris F.H., Helvering L., Morrison P., Rosteck P., Lai M., Barrett J.C., Lewis C., Neuhausen S., Cannon-Albright L., Goldgar D., Wiseman R., Kamb A., and Skolnick M.H. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266 (1994) 66-71
2. Couch F.J., and Weber B.L. Mutations and polymorphisms in the familial early-onset breast cancer (BRCA1) gene. Breast Cancer Information Core. Hum. Mutat. 8 (1996) 8-18
3. Koonin E.V., Altschul S.F., and Bork P. BRCA1 protein products. Functional motifs?. Nat. Genet. 13 (1996) 266-267
4. Henderson B.R. Regulation of BRCA1, BRCA2 and BARD1 intracellular trafficking. Bioessays 27 (2005) 884-893
5. Baer R., and Ludwig T. The BRCA1/BARD1 heterodimer, a tumor suppressor complex with ubiquitin E3 ligase activity. Curr. Opin. Genet. Dev. 12 (2002) 86-91
6. Fabbro M., Rodriguez J.A., Baer R., and Henderson B.R. BARD1 induces BRCA1 intranuclear foci formation by increasing RING-dependent BRCA1 nuclear import and inhibiting BRCA1 nuclear export. J. Biol. Chem. 277 (2002) 21315-21324
7. Irminger-Finger I., and Jefford C.E. Is there more to BARD1 than BRCA1?. Nat. Rev. Cancer 6 (2006) 382-391
8. Mallery D.L., Vandenberg C.J., and Hiom K. Activation of the E3 ligase function of the BRCA1/BARD1 complex by polyubiquitin chains. EMBO J. 21 (2002) 6755-6762
9. Starita L.M., Machida Y., Sankaran S., Elias J.E., Griffin K., Schlegel B.P., Gygi S.P., and Parvin J.D. BRCA1-dependent ubiquitination of gamma-tubulin regulates centrosome number. Mol. Cell. Biol. 24 (2004) 8457-8466
10. Somasundaram K., Zang H., Zeng Y.-X., Houvras Y., Peng Y., Zhang H., Wu G.S., Licht J., Weber B.L., and El-Deiry W.S. Arrest of the cell cycle by the tumour-suppressor BRCA1 requires the CDK-inhibitor p21WAF1/CiP1. Nature 389 (1997) 187-190
11. Chapman M.S., and Verma I.M. Transcriptional activation by BRCA1. Nature 382 (1996) 678-679
12. Monteiro A.N.A., August A., and Hanafusa H. Evidence for a transcriptional activation function of BRCA1 C-terminal region. Proc. Nat. Acad. Sci. USA 93 (1996) 13595-13599
13. Scully R., Anderson S.F., Chao D.M., Wei W., Ye L., Young R.A., Livingston D.M., and Parvin J.D. BRCA1 is a component of the RNA polymerase II holoenzyme. Proc. Nat. Acad. Sci. USA 94 (1997) 5605-5610
14. Chai Y., Cui J.-Q., Shao N., Reddy E.S.P., and Rao V.N. The second BRCT domain of BRCA1 proteins interacts with p53 and stimulates transcription from the p21WAF1/CIP1 promoter. Oncogene 18 (1999) 263-268
15. Li S., Chen P.-L., Subramanian T., Chinnadurai G., Tomlinson G., Osborne C.K., Sharp Z.D., and Lee W.-H. Binding of CtIP to the BRCT repeats of BRCA1 involved in the transcription regulation of p21 is disrupted upon DNA damage. J. Biol. Chem. 274 (1999) 11334-11338
16. Horwitz A.A., Sankaran S., and Parvin J.D. Direct stimulation of transcription initiation by BRCA1 requires both its amino and carboxyl termini. J. Biol. Chem. 281 (2006) 8317-8320
17. Kleiman F.E., Wu-Baer F., Fonseca D., Kaneko S., Baer R., and Manley J.L. BRCA1/BARD1 inhibition of mRNA 3' processing involves targeted degradation of RNA polymerase II. Genes Dev. 19 (2005) 1227-1237
18. Horwitz A.A., Affar e.B., Heine G.F., Shi Y., and Parvin J.D. A mechanism for transcriptional repression dependent on the BRCA1 E3 ubiquitin ligase. Proc. Nat. Acad. Sci. USA 104 (2007) 6614-6619
19. Rodriguez J.A., and Henderson B.R. Identification of a functional nuclear export sequence in BRCA1. J. Biol. Chem. 275 (2000) 38589-38596
20. Fabbro M., Schuechner S., Au W.W., and Henderson B.R. BARD-1 regulates BRCA1 apoptotic function by a mechanism involving nuclear retention. Exp. Cell Res. 298 (2004) 661-673
21. Fan W., Jin S., Tong T., Zhao H., Fan F., Antinore M.J., Rajasekaran B., Wu N., and Zhan Q. BRCA1 regulates GADD45 through its interactions with the OCT-1 and CAAT motifs. J. Biol. Chem. 277 (2002) 8061-8067
22. Ouchi T., Monteiro A.N., August A., Aaronson S.A., and Hanafusa H. BRCA1 regulates p53-dependent gene expression. Proc. Nat. Acad. Sci. USA 95 (1998) 2302-2306
23. Brzovic P.S., Rajagopal P., Hoyt D.W., King M.C., and Klevit R.E. Structure of a BRCA1-BARD1 heterodimeric RING-RING complex. Nat. Struct. Biol. 8 (2001) 833-837
24. Hashizume R., Fukuda M., Maeda I., Nishikawa H., Oyake D., Yabuki Y., Ogata H., and Ohta T. The RING heterodimer BRCA1-BARD1 is a ubiquitin ligase inactivated by a breast cancer-derived mutation. J. Biol. Chem. 276 (2001) 14537-14540
25. Ruffner H., Joazeiro C.A.P., Hemmati D., Hunter T., and Verma I.M. Cancer-predisposing mutations within the RING domain of BRCA1: loss of ubiquitin protein ligase activity and protection from radiation hypersensitivity. Proc. Nat. Acad. Sci. USA 98 (2001) 5134-5139
26. Harkin D.P., Bean J.M., Miklos D., Song Y.H., Truong V.B., Englert C., Christians F.C., Ellisen L.W., Maheswaran S., Oliner J.D., and Haber D.A. Induction of GADD45 and JNK/SAPK-dependent apoptosis following inducible expression of BRCA1. Cell 97 (1999) 575-586
27. Starita L.M., Horwitz A.A., Keogh M.C., Ishioka C., Parvin J.D., and Chiba N. BRCA1/BARD1 ubiquitinate phosphorylated RNA polymerase II. J. Biol. Chem. 280 (2005) 24498-24505
28. Yu X., Wu L.C., Bowcock A.M., Aronheim A., and Baer R. The C-terminal (BRCT) domains of BRCA1 interact in vivo with CtIP, a protein implicated in the CtBP pathway of transcriptional repression. J. Biol. Chem. 273 (1998) 25388-25392
29. Schüchner S., Tembe V., Rodriguez J.A., and Henderson B.R. Nuclear targeting and cell cycle regulatory function of human BARD1. J. Biol. Chem. 280 (2005) 8855-8861
30. Taylor J., Lymboura M., Pace P.E., A'hern R.P., Desai A.J., Shousha S., Coombes R.C., and Ali S. An important role for BRCA1 in breast cancer progression is indicated by its loss in a large proportion of non-familial breast cancers. Int. J. Cancer 79 (1998) 334-342